Articles
Volume 13 Supplement 2
IX Madrid Breast Cancer Conference
- Meeting abstracts
- from IX Madrid Breast Cancer Conference
- Madrid, Spain
- 16-17 November 2011
|
Oral presentation
L Pusztai Breast Cancer Research 2011, 13(Suppl 2):O1 (16 November 2011) |
|
Oral presentation
Molecular classification of triple-negative tumors A Prat, CM Perou Breast Cancer Research 2011, 13(Suppl 2):O2 (16 November 2011) |
|
Oral presentation
Poly(ADP-ribose) polymerase inhibitor development: are we in the right direction? R Plummer Breast Cancer Research 2011, 13(Suppl 2):O3 (16 November 2011) |
|
Oral presentation
Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma JP Thiery, WJ Sim, K Chua, R Huang, S Mori, T Tan, FC Bidart, JY Pierga Breast Cancer Research 2011, 13(Suppl 2):O5 (16 November 2011) |
|
Oral presentation
M Esteller Breast Cancer Research 2011, 13(Suppl 2):O6 (16 November 2011) |
|
Oral presentation
Immunity and autoimmunity in breast cancer G Curigliano Breast Cancer Research 2011, 13(Suppl 2):O4 (16 November 2011) |
|
Oral presentation
Insulin resistance in breast cancer: relevance and clinical implications PJ Goodwin Breast Cancer Research 2011, 13(Suppl 2):O7 (16 November 2011) |
|
Oral presentation
The phosphatidylinositol-3 kinase/mTOR pathway: new agents CL Arteaga Breast Cancer Research 2011, 13(Suppl 2):O8 (16 November 2011) |
|
Oral presentation
DNA repair and breast cancer: therapeutic opportunities DP Silver Breast Cancer Research 2011, 13(Suppl 2):O9 (16 November 2011) |
|
Oral presentation
NoncodingRNAs: from bench to bedside GA Calin Breast Cancer Research 2011, 13(Suppl 2):O10 (16 November 2011) |
|
Oral presentation
Targeting HER2 in breast cancer: beyond trastuzumab EP Winer Breast Cancer Research 2011, 13(Suppl 2):O11 (16 November 2011) |
|
Oral presentation
J Baselga, F Costa, H Gomez, C Hudis, B Rapoport, H Roche, LS Schwartzberg, O Petrenciuc, M Shan, WJ Gradishar Breast Cancer Research 2011, 13(Suppl 2):O12 (16 November 2011) |
|
Oral presentation
Molecular heterogeneity of luminal breast cancer S Loi Breast Cancer Research 2011, 13(Suppl 2):O13 (16 November 2011) |
|
Oral presentation
Translational breast cancer research in luminal breast cancer M Dowsett Breast Cancer Research 2011, 13(Suppl 2):O14 (16 November 2011) |
|
Oral presentation
Interpretation and molecular validation of biomarker studies JS Reis-Filho Breast Cancer Research 2011, 13(Suppl 2):O15 (16 November 2011) |
|
Poster presentation
Clinical features and prognosis of tubular breast cancer M Izquierdo Sanz, F Tresserra Casas, G Nacho Rodríguez, R Fabregas Xaurado, M Cusido Gimferrer, C Ara Perez, S Baulies Caballero Breast Cancer Research 2011, 13(Suppl 2):P1 (16 November 2011) |
|
Poster presentation
Breast Cancer Research 2011, 13(Suppl 2):P2 (16 November 2011) |
|
Poster presentation
Nestin and collagen triple helix repeat containing 1 in breast cancer progression G Kharaishvili, D Simkova, M Cizkova, K Bouchalova, G Mgebrishvili, Z Kolar, J Bouchal Breast Cancer Research 2011, 13(Suppl 2):P3 (16 November 2011) |
|
Poster presentation
L Manso, E Ciruelos, M Codes, J De la Haba, A Galan, J Baena, A Jaen, M Gil, A Murias, I Blancas, E Gonzalez, D Perez, JL Bayo, J Mel, E Garcia-Martinez, R Cubedo, J Salvador Breast Cancer Research 2011, 13(Suppl 2):P4 (16 November 2011) |
|
Poster presentation
JWK Lee, CTM Ong, EY Tan, MYP Chan Breast Cancer Research 2011, 13(Suppl 2):P5 (16 November 2011) |
|
Poster presentation
Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value E Ciruelos, C Castaneda, T Pascual, E Andrés, HL Gomez, L Manso, N Valdivieso, I Ghanem, H Cortes-Funes Breast Cancer Research 2011, 13(Suppl 2):P6 (16 November 2011) |
|
Poster presentation
Lobular carcinoma of the breast: outcome of 205 patients E Vega, E Ciruelos, N Valdiviezo, C Mendiola, L Manso, I Ghanem, M Dorta, T Pascual, C Flores, H Cortés-Funes Breast Cancer Research 2011, 13(Suppl 2):P7 (16 November 2011) |
|
Poster presentation
BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients K Bouchalova, M Cizkova, R Trojanec, V Koudelakova, L Radova, J Furstova, B Melichar, K Cwiertka, G Kharaishvili, Z Kolar, M Hajduch Breast Cancer Research 2011, 13(Suppl 2):P8 (16 November 2011) |
|
Poster presentation
Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin R Trojanec, V Koudelakova, K Bouchalova, L Radova, H Ondryasova, E Krejci, M Megova, M Cizkova, S Mlcochova, B Melichar, M Hajduch Breast Cancer Research 2011, 13(Suppl 2):P9 (16 November 2011) |
|
Poster presentation
microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples A Gámez-Pozo, I Sánchez-Navarro, CA Castaneda, NI Ferrer, G de Velasco, FG Martínez, E Ciruelos, JÁ Fresno Vara Breast Cancer Research 2011, 13(Suppl 2):P10 (16 November 2011) |
|
Poster presentation
S Løkkegaard, M Bennetzen, D Elias, A Lykkesfeldt, LE Johansen, R Leth-Larsen, JS Andersen, HJ Ditzel Breast Cancer Research 2011, 13(Suppl 2):P11 (16 November 2011) |
|
Poster presentation
KH Gravgaard, MB Lyng, A-V Laenkholm, R Søkilde, BS Nielsen, T Litman, HJ Ditzel Breast Cancer Research 2011, 13(Suppl 2):P12 (16 November 2011) |
